Amneal to Virtually Participate at Morgan Stanley 19th Annual Global Healthcare ConferenceBusiness Wire • 09/07/21
Amneal Announces Positive Topline Results from Pivotal Phase 3 RISE-PD Clinical Trial of IPX-203 in Patients with Parkinson's Disease Who Experience Motor FluctuationsBusiness Wire • 08/25/21
Amneal Announces Virtual Event to Discuss Initial Data from Pivotal Phase 3 Study of IPX-203 in Patients with Parkinson's Disease Who Experience Motor FluctuationsBusiness Wire • 08/23/21
Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/09/21
Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 08/02/21
Amneal Announces U.S. FDA Filing Acceptance of Biologics License Application (BLA) for BevacizumabBusiness Wire • 06/17/21
Amneal Announces Dihydroergotamine (DHE) Autoinjector NDA for Migraines and Cluster HeadachesBusiness Wire • 06/07/21
Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/07/21
Earnings Preview: Amneal Pharmaceuticals (AMRX) Q1 Earnings Expected to DeclineZacks Investment Research • 04/30/21